日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A patient derived xenograft repository capturing clinical and molecular heterogeneity of large B-cell lymphoma

一个源自患者的异种移植模型库,用于捕捉大B细胞淋巴瘤的临床和分子异质性

Yang, Haopeng; Arita, Kotaro; Bowman, Kevin; Chihara, Dai; Henderson, Jared; Rost, Griffin; Rojas, Estela; Parsons, Sydney; Lakra, Priya; Abedin, Aneela; Neelapu, Sattva S; Strati, Paolo; Nastoupil, Loretta J; Fayad, Luis; Iyer, Swaminathan P; Rodriguez, Alma; Hagemeister, Frederick B; Malpica, Luis; Lee, Hun Ju; Hilton, Laura; Scott, David W; Davis, Richard Eric; Flowers, Christopher R; Westin, Jason R; Inghirami, Giorgio; Vega, Francisco; Green, Michael R

Allogeneic Chimeric Antigen Receptor T-Cell Products Cemacabtagene Ansegedleucel/ALLO-501 in Relapsed/Refractory Large B-Cell Lymphoma: Phase I Experience From the ALPHA2/ALPHA Clinical Studies

异基因嵌合抗原受体T细胞产品Cemacabtagene Ansegedleucel/ALLO-501治疗复发/难治性大B细胞淋巴瘤:ALPHA2/ALPHA临床研究的I期经验

Locke, Frederick L; Munoz, Javier L; Tees, Michael T; Lekakis, Lazaros J; de Vos, Sven; Nath, Rajneesh; Stevens, Don A; Malik, Shahbaz A; Shouse, Geoffrey P; Hamadani, Mehdi; Oluwole, Olalekan O; Perales, Miguel-Angel; Miklos, David B; Fisher, Paul W; Feng, Amy; Navale, Lynn; Le Gall, John B; Neelapu, Sattva S

Five-Year Follow-Up Analysis of ZUMA-5: Axicabtagene Ciloleucel in Relapsed/Refractory Indolent Non-Hodgkin Lymphoma

ZUMA-5 五年随访分析:Axicabtagene Ciloleucel 治疗复发/难治性惰性非霍奇金淋巴瘤

Neelapu, Sattva S; Chavez, Julio C; Sehgal, Alison R; Epperla, Narendranath; Ulrickson, Matthew L; Bachy, Emmanuel; Munshi, Pashna N; Casulo, Carla; Maloney, David G; de Vos, Sven; Reshef, Ran; Leslie, Lori A; Oluwole, Olalekan O; Yakoub-Agha, Ibrahim; Khanal, Rashmi; Rosenblatt, Joseph D; Wulff, Jacob; Shen, Rhine R; Zhang, Wangshu; Poddar, Soumya; Miao, Harry; Nikolajeva, Olga; Jacobson, Caron A

Blunted CD40-responsive enhancer activation in CREBBP-mutant lymphomas can be restored by enforced CD4 T-cell engagement

CREBBP突变淋巴瘤中CD40反应性增强子激活减弱可通过强制CD4 T细胞参与来恢复。

Yang, Haopeng; Zhang, Wenchao; Ravanmehr, Vida; Cui, Guiling; Bowman, Kevin; Chen, Ruidong; Henderson, Jared M; Lockman, Shyanne; Rojas, Estela; Wilson, Ashley; Parsons, Sydney; Mechaly, Ariel; Regad, Leslie; Haouz, Ahmed; Flowers, Christopher R; Neelapu, Sattva; Nastoupil, Loretta; Davis, R Eric; Deng, Qing; Rodrigues-Lima, Fernando; Green, Michael R

Antibiotic-induced loss of gut microbiome metabolic output correlates with clinical responses to CAR T-cell therapy

抗生素引起的肠道微生物群代谢输出下降与CAR-T细胞疗法的临床反应相关

Prasad, Rishika; Rehman, Abdur; Rehman, Lubna; Darbaniyan, Faezeh; Blumenberg, Viktoria; Schubert, Maria-Luisa; Mor, Uria; Zamir, Eli; Schmidt, Sabine; Hayase, Tomo; Chang, Chia-Chi; McDaniel, Lauren; Flores, Ivonne; Strati, Paolo; Nair, Ranjit; Chihara, Dai; Fayad, Luis E; Ahmed, Sairah; Iyer, Swaminathan P; Wang, Michael; Jain, Preetesh; Nastoupil, Loretta J; Westin, Jason; Arora, Reetakshi; Turner, Joel; Khawaja, Fareed; Wu, Ranran; Dennison, Jennifer B; Menges, Meghan; Hidalgo-Vargas, Melanie; Reid, Kayla; Davila, Marco L; Dreger, Peter; Korell, Felix; Schmitt, Anita; Tanner, Mark R; Champlin, Richard E; Flowers, Christopher R; Shpall, Elizabeth J; Hanash, Samir; Neelapu, Sattva S; Schmitt, Michael; Subklewe, Marion; Francois-Fahrmann, Johannes; Stein-Thoeringer, C K; Elinav, Eran; Jain, Michael D; Hayase, Eiko; Jenq, Robert R; Saini, Neeraj Y

Frontline acalabrutinib, lenalidomide and rituximab for advanced stage follicular lymphoma with high tumor burden: phase II trial

一线治疗高肿瘤负荷晚期滤泡性淋巴瘤:阿卡替尼、来那度胺和利妥昔单抗联合方案:II期试验

Strati, Paolo; Feng, Lei; Westin, Jason R; Nair, Ranjit; Fayad, Luis E; Rodriguez, Maria A; Chihara, Dai; Malpica, Luis; Henderson, Jared; Gallardo, Mariana; Rivera, Marissa; Wang, Iris; Bolshakova, Anastasiia; Radko, Anastasia; Kurtz, David; Alig, Stefan K; Flowers, Christopher R; Alizadeh, Ash A; Neelapu, Sattva S

Clinical, tumor, and product features associated with outcomes after axicabtagene ciloleucel therapy in follicular lymphoma

滤泡性淋巴瘤患者接受axicabtagene ciloleucel治疗后,与疗效相关的临床、肿瘤和产品特征

Soumya Poddar ,Jiali Yan ,Gayatri Tiwari ,Darawan Rinchai ,Justin Budka ,Wangshu Zhang ,Weixin Peng ,Shruti Salunkhe ,Madison Davis ,Qinghua Song ,Sara Beygi ,Harry Miao ,Mike Mattie ,Rhine S Shen ,Caron A Jacobson ,Davide Bedognetti ,Simone Filosto ,Sattva S Neelapu

Germline determinants of toxicity and efficacy in patients with large B-cell lymphoma treated with CAR T-cell therapy

CAR-T细胞疗法治疗大B细胞淋巴瘤患者的毒性和疗效的种系决定因素

Strati, Paolo; Brandt, Amanda; Lionel, Anath C; Henderson, Jared; Westin, Jason R; Adkins, Sherry; Shpall, Elizabeth J; Kebriaei, Partow; Ramdial, Jeremy; Saini, Neeraj; Ahmed, Sairah; Flowers, Christopher; Neelapu, Sattva S; Hildebrandt, Michelle A T

A Phase I Trial of Evorpacept, Lenalidomide and Rituximab for Patients with B-cell Non-Hodgkin Lymphoma.

Evorpacept、来那度胺和利妥昔单抗治疗 B 细胞非霍奇金淋巴瘤患者的 I 期试验

Strati Paolo, Feng Lei, Tyshevich Andrey, Shavronskaya Darya, Alesse Julia, English Noel, Sheehan Elizabeth, Syzrantsev Nikita, Nesmelov Alexander, Zhuang Tony Z, Chihara Dai, Westin Jason R, Ahmed Sairah, Fayad Luis E, Henderson Jared, Dent Kylie, McChesney Elizabeth, Neelapu Sattva S, Flowers Christopher R

Cytokine Storms in COVID-19, Hemophagocytic Lymphohistiocytosis, and CAR-T Therapy

COVID-19、噬血细胞性淋巴组织细胞增生症和CAR-T疗法中的细胞因子风暴

Long, James P; Prakash, Rishab; Edelkamp, Paul Jr; Knafl, Mark; Lionel, Anath C; Nair, Ranjit; Ahmed, Sairah; Strati, Paolo; Castillo, Luis E Malpica; Al-Zaki, Ajlan; Chien, Kelly; Chihara, Dai; Westin, Jason; Khawaja, Fareed; Nastoupil, Loretta J; Mulanovich, Victor; Futreal, Andrew; Woodman, Scott E; Daver, Naval G; Flowers, Christopher R; Neelapu, Sattva; Manzano, Joanna-Grace; Iyer, Swaminathan P